With an ageing population, a number of cardiovascular diseases are becoming more prevalent. Despite its prevalence, there are still many cases of structural heart disease that are misdiagnosed.
Echo IQ’s AI-powered solution brings a new level of assessment to healthcare professionals as they seek to identify life-threatening but treatable conditions, to bring treatment closer to patients and reduce the risk of misdiagnosis. Through these efforts, patients benefit from knowing that technology is being harnessed for maximum impact.
Conditions assessed include;
This proprietary digital (cloud-based) solution is designed to show probality indicators for structural heart disease using echocardiographic measurement data from a standard cardiothoracic ultrasound. Our innovative diagnostic tool will analyse this data to generate a risk indicator. This will be augmented by an additional checks, alongside AI and machine learning.
ACCURACY IN RISK PREDICTION
Reassurance knowing that human intelligence is supplemented by AI-driven technology backed by hundreds of millions of cardiac data points. It is essential that we begin correcting the issues of misdiagnosis, and we believe that this screening process will allow us to do just that. With this technology, we aim to remove clinical bias and human error, thus improving the speed of identifying patients at risk.
PEACE OF MIND
Providing you with the peace of mind that all variables have been considered in order to deliver optimal care. MyEcho Insight has been designed to provide early, accurate and improved diagnosis of structural heart disease. With this technology, we aim to remove clinical bias and human error, thus improving the speed of identifying patients at risk.
Contact Us Today
Have any questions for us regarding our diagnostic tools? Feel free to get in touch with us.